ABCL Competitors & Alternatives
Compare Abcellera Biologics Inc with similar stocks in the same industry
Biotechnology
ABCL
Main Stock$11.32
Tradestie Score
40
Market Cap
$1.78B
Revenue Growth
-0.8%
Analyst Upside
+51.3%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PTGX
Protagonist Therapeutics, Inc
|
$154.32
|
$3.98B | 153.4 | 43 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.69
|
$3.92B | - | 40 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$119.80
|
$3.91B | - | 38 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$26.01
|
$3.83B | - | 33 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$17.00
|
$3.68B | - | 51 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$96.31
|
$3.67B | - | 66 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$9.84
|
$3.59B | 13.9 | 40 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$29.50
|
$3.58B | 13.6 | 48 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$286.29
|
$3.49B | 29.9 | 60 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$11.33
|
$3.40B | - | 37 | Compare |
More ABCL Analysis
Data updated: Aug 22, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry